miR-21 promotes human nucleus pulposus cell proliferation through PTEN/AKT signaling

International Journal of Molecular Sciences

Volumn 15, Issue 3, 2014, Pages 4007-4018

  Liu, Hongzhe ^a   Huang, Xiangwang ^a   Liu, Xiangyang ^a   Xiao, Sheng ^a   Zhang, Yi ^a   Xiang, Tiecheng ^a   Shen, Xiongjie ^a   Wang, Guoping ^a   Sheng, Bin ^a  

^a Hunan Provincial People's Hospital   (China)

Author keywords

Disc degeneration; miR 21; miRNA; Nucleus pulposus cells; Proliferation

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CYCLIN D1; MICRORNA 10B; MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; 3' UNTRANSLATED REGION; MICRORNA; MIRN21 MICRORNA, HUMAN;

ADULT; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IDIOPATHIC SCOLIOSIS; IMMUNOBLOTTING; INTERVERTEBRAL DISK DEGENERATION; MAJOR CLINICAL STUDY; MIDDLE AGED; NUCLEUS PULPOSUS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; YOUNG ADULT; 3' UNTRANSLATED REGION; ADOLESCENT; CELL CULTURE; FEMALE; GENETICS; MALE; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHOSPHORYLATION; PRIMARY CELL CULTURE; SCOLIOSIS;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; BASE SEQUENCE; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HUMANS; INTERVERTEBRAL DISC DEGENERATION; MALE; MICRORNAS; MIDDLE AGED; MUTATION; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCOLIOSIS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84896452321     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15034007     Document Type: Article

References (37)

1. Frymoyer, J. W.; Cats-Baril, W. L. An overview of the incidences and costs of low back pain. Orthop. Clin. N. Am. 1991, 22, 263-271.
2. Nakamura, M.; Nishiwaki, Y.; Ushida, T.; Toyama, Y. Prevalence and characteristics of chronic musculoskeletal pain in Japan. J. Orthop. Sci. 2011, 16, 424-432.
3. Samartzis, D.; Karppinen, J.; Mok, F.; Fong, D. Y.; Luk, K. D.; Cheung, K. M. A population-based study of juvenile disc degeneration and its association with overweight and obesity, low back pain, and diminished functional status. J. Bone Jt. Surg. Am. 2011, 93, 662-670.
4. Hangai, M.; Kaneoka, K.; Kuno, S.; Hinotsu, S.; Sakane, M.; Mamizuka, N.; Sakai, S.; Ochiai, N. Factors associated with lumbar intervertebral disc degeneration in the elderly. Spine J. 2008, 8, 732-740.
5. Katz, J. N. Lumbar disc disorders and low-back pain: Socioeconomic factors and consequences. J. Bone Jt. Surg. Am. 2006, 88, 21-24.
6. Johnson, W. E.; Eisenstein, S. M.; Roberts, S. Cell cluster formation in degenerate lumbar intervertebral discs is associated with increased disc cell proliferation. Connect. Tissue Res. 2001, 42, 197-207.
7. Li, Z.; Shen, J.; Wu, W. K.; Yu, X.; Liang, J.; Qiu, G.; Liu, J. Leptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK/STAT, PI3K/Akt and MEK/ERK pathways. PLoS One 2012, 7, e53176.
8. Farazi, T. A.; Spitzer, J. I.; Morozov, P.; Tuschl, T. miRNAs in human cancer. J. Pathol. 2011, 223, 102-115.
9. Ferland-McCollough, D.; Ozanne, S. E.; Siddle, K.; Willis, A. E.; Bushell, M. The involvement of microRNAs in Type 2 diabetes. Biochem. Soc. Trans. 2010, 38, 1565-1570.
10. Mo, Y. Y. MicroRNA regulatory networks and human disease. Cell. Mol. Life Sci. 2012, 69, 3529-3531.
11. Yates, L. A.; Norbury, C. J.; Gilbert, R. J. The long and short of microRNA. Cell 2013, 153, 516-519.
12. Chou, J.; Shahi, P.; Werb, Z. MicroRNA-mediated regulation of the tumor microenvironment. Cell Cycle 2013, 12, 3262-3271.
13. Xie, Z. R.; Yang, H. T.; Liu, W. C.; Hwang, M. J. The role of microRNA in the delayed negative feedback regulation of gene expression. Biochem. Biophys. Res. Commun. 2007, 358, 722-726.
14. Roy, S.; Sen, C. K. MiRNA in innate immune responses: Novel players in wound inflammation. Physiol. Genomics 2011, 43, 557-565.
15. Orso, F.; Balzac, F.; Marino, M.; Lembo, A.; Retta, S. F.; Taverna, D. miR-21 coordinates tumor growth and modulates KRIT1 levels. Biochem. Biophys. Res. Commun. 2013, 438, 90-96.
16. Zhang, Y. X.; Yue, Z.; Wang, P. Y.; Li, Y. J.; Xin, J. X.; Pang, M.; Zheng, Q. Y.; Xie, S. Y. Cisplatin upregulates MSH2 expression by reducing miR-21 to inhibit A549 cell growth. Biomed. Pharmacother. 2013, 67, 97-102.
17. Toiyama, Y.; Takahashi, M.; Hur, K.; Nagasaka, T.; Tanaka, K.; Inoue, Y.; Kusunoki, M.; Boland, C. R.; Goel, A. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer. J. Natl. Cancer Inst. 2013, 105, 849-859.
18. Vicinus, B.; Rubie, C.; Stegmaier, N.; Frick, V. O.; Kolsch, K.; Kauffels, A.; Ghadjar, P.; Wagner, M.; Glanemann, M. miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: Significance of their regulation. Oncol. Rep. 2013, 30, 1285-1292.
19. Wang, P.; Zhuang, L.; Zhang, J.; Fan, J.; Luo, J.; Chen, H.; Wang, K.; Liu, L.; Chen, Z.; Meng, Z. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL. Mol. Oncol. 2013, 7, 334-345.
20. Wang, N.; Zhang, C. Q.; He, J. H.; Duan, X. F.; Wang, Y. Y.; Ji, X.; Zang, W. Q.; Li, M.; Ma, Y. Y.; Wang, T.; et al. MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig. Dis. Sci. 2013, 58, 1863-1870.
21. Xiong, B.; Cheng, Y.; Ma, L.; Zhang, C. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells. Int. J. Oncol. 2013, 42, 219-228.
22. Kongcharoensombat, W.; Nakasa, T.; Ishikawa, M.; Nakamae, A.; Deie, M.; Adachi, N.; Mohamed, A.; Ochi, M. The effect of microRNA-21 on proliferation and matrix synthesis of chondrocytes embedded in atelocollagen gel. Knee Surg. Sports Traumatol. Arthrosc. 2010, 18, 1679-1684.
23. Wang, H. Q.; Yu, X. D.; Liu, Z. H.; Cheng, X.; Samartzis, D.; Jia, L. T.; Wu, S. X.; Huang, J.; Chen, J.; Luo, Z. J. Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3. J. Pathol. 2011, 225, 232-242.
24. Yu, X.; Li, Z.; Shen, J.; Wu, W. K.; Liang, J.; Weng, X.; Qiu, G. MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervetebral disc degeneration. PLoS One 2013, 8, e83080.
25. Van Wynsberghe, P. M.; Chan, S. P.; Slack, F. J.; Pasquinelli, A. E. Analysis of microRNA expression and function. Methods Cell Biol. 2011, 106, 219-252.
26. Bhagat, T. D.; Zhou, L.; Sokol, L.; Kessel, R.; Caceres, G.; Gundabolu, K.; Tamari, R.; Gordon, S.; Mantzaris, I.; Jodlowski, T.; et al. miR-21 mediates hematopoietic suppression in MDS by activating TGF-beta signaling. Blood 2013, 121, 2875-2881.
27. Capodanno, A.; Boldrini, L.; Proietti, A.; Ali, G.; Pelliccioni, S.; Niccoli, C.; D'Incecco, A.; Cappuzzo, F.; Chella, A.; Lucchi, M.; et al. Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features. Int. J. Oncol. 2013, 43, 765-774.
28. Schee, K.; Boye, K.; Abrahamsen, T. W.; Fodstad, O.; Flatmark, K. Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer. BMC Cancer 2012, 12, 505.
29. Seca, H.; Lima, R. T.; Lopes-Rodrigues, V.; Guimaraes, J. E.; Almeida, G. M.; Vasconcelos, M. H. Targeting miR-21 induces autophagy and chemosensitivity of leukemia cells. Curr. Drug Targets 2013, 14, 1135-1143.
30. Sicard, F.; Gayral, M.; Lulka, H.; Buscail, L.; Cordelier, P. Targeting miR-21 for the therapy of pancreatic cancer. Mol. Ther. 2013, 21, 986-994.
31. Tao, T.; Wang, Y.; Luo, H.; Yao, L.; Wang, L.; Wang, J.; Yan, W.; Zhang, J.; Wang, H.; Shi, Y.; et al. Involvement of FOS-mediated miR-181b/miR-21 signalling in the progression of malignant gliomas. Eur. J. Cancer 2013, 49, 3055-3063.
32. Soria-Valles, C.; Gutierrez-Fernandez, A.; Guiu, M.; Mari, B.; Fueyo, A.; Gomis, R. R.; Lopez-Otin, C. The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21. Oncogene 2013, doi: 10. 1038/onc. 2013. 267.
33. Yang, S. M.; Huang, C.; Li, X. F.; Yu, M. Z.; He, Y.; Li, J. miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology 2013, 306, 162-168.
34. Chappell, W. H.; Steelman, L. S.; Long, J. M.; Kempf, R. C.; Abrams, S. L.; Franklin, R. A.; Basecke, J.; Stivala, F.; Donia, M.; Fagone, P.; et al. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget 2011, 2, 135-164.
35. Hyun, T.; Yam, A.; Pece, S.; Xie, X.; Zhang, J.; Miki, T.; Gutkind, J. S.; Li, W. Loss of PTEN expression leading to high Akt activation in human multiple myelomas. Blood 2000, 96, 3560-3568.
36. Pfirrmann, C. W.; Metzdorf, A.; Zanetti, M.; Hodler, J.; Boos, N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine 2001, 26, 1873-1878.
37. Li, Z.; Shen, J.; Wu, W. K.; Yu, X.; Liang, J.; Qiu, G.; Liu, J. The role of leptin on the organization and expression of cytoskeleton elements in nucleus pulposus cells. J. Orthop. Res. 2013, 31, 847-857.